Diet Starts Monday: An Analysis of Current U.S. Dietary Supplement Regulations Through an International Comparison by Lindquist, Greg
Saint Louis University Journal of Health Law & Policy 
Volume 3 




Diet Starts Monday: An Analysis of Current U.S. Dietary 
Supplement Regulations Through an International Comparison 
Greg Lindquist 
gregory.lindquist@gmail.com 
Follow this and additional works at: https://scholarship.law.slu.edu/jhlp 
 Part of the Health Law and Policy Commons 
Recommended Citation 
Greg Lindquist, Diet Starts Monday: An Analysis of Current U.S. Dietary Supplement Regulations Through 
an International Comparison, 3 St. Louis U. J. Health L. & Pol'y (2009). 
Available at: https://scholarship.law.slu.edu/jhlp/vol3/iss1/8 
This Student Comment is brought to you for free and open access by Scholarship Commons. It has been accepted 
for inclusion in Saint Louis University Journal of Health Law & Policy by an authorized editor of Scholarship 
Commons. For more information, please contact Susie Lee. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
 
123 
DIET STARTS MONDAY: 
AN ANALYSIS OF CURRENT U.S. DIETARY SUPPLEMENT REGULATIONS 
THROUGH AN INTERNATIONAL COMPARISON 
I.  INTRODUCTION 
It only takes a few moments walking through a grocery store, browsing 
through a magazine, or even just flipping through the channels to 
understand the massive role that dietary supplements play in American 
culture.  In 2008, American consumers spent roughly $25 billion on dietary 
supplements,1 making up a sizeable portion of the massive $228.3 billion 
global nutrition industry.2  Dietary supplement use has soared in popularity 
to an estimated 150 million Americans3—approximately half of the U.S. 
population.4  In line with their popularity in the United States, dietary 
supplements are highly popular abroad as well.  Up to seventy percent of all 
Canadians take some form of supplement5 and European consumers are 
responsible for roughly seventeen percent of the entire global dietary 
 
 1. Carlotta Mast, Supplement Industry Adds $61 Billion to U.S. Economy, NUTRITION 
BUS. J., May 28, 2009, http://blog.nutritionbusinessjournal.com/nbj/2009/05/28/supple 
ment-industry-adds-61-billion-to-us-economy/.  See also Patrick Rea, 2009 Supplement 
Industry – What Can We Expect?, NUTRITION BUS. J., Nov. 11, 2008, http://blog.nutrition 
businessjournal.com/nbj/2008/11/11/2009-supplement-industry-what-can-we-expect/ 
(noting that in 2008, in spite of the economic downturn, total sales figures would likely be 
higher than 2007 due to sales-growth in multivitamins and a renewal of consumer interest in 
herbs and vitamin D). 
 2. NUTRITION BUS. J., GLOBAL SUPPLEMENT & NUTRITION INDUSTRY REPORT 2007 (2007), 
http://nutritionbusinessjournal.com/nutrition-industry/market-research/global_supplement_ 
nutrition_industry_report_2007/index.html (demonstrating the global nutrition industry 
includes dietary supplements, but also includes other products like natural and organic foods). 
 3. Press Release, Council for Responsible Nutrition, Issues Surrounding Healthcare Key 
Priority for Supplement Users (Jan. 15, 2009), available at http://www.crnusa.org/prpdfs/ 
CRNPR09_ConsumerHC011509.pdf. 
 4. See Press Release, U.S. Census Bureau, Census Bureau Projects U.S. Population of 
305.5 Million on New Year’s Day (Dec. 29, 2008), available at http://www.census.gov/Press 
Release/www/releases/archives/population/013127.html. 
 5. CANADIAN HEALTH FOOD ASS’N, Western Canadians Big Users of Natural Health 
Products in a $2.5 Billion Dollar Industry (Apr. 7, 2007) (on file with author) (statement of 
Canadian Health Food Association president Valerie Bell) (“Canada’s natural health products 
sector has become a significant contributor to the Canadian economy.”). 
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supplement market.6  Due to the popularity of dietary supplements and the 
increasing size of the global industry, the importance of product safety has 
grown into a main concern for governmental regulatory bodies.7 
Depending on the country, dietary supplements may have different 
definitions and different levels of regulation, if any.  In the United States, 
dietary supplements are classified by the Dietary Supplement Health and 
Education Act of 1994 (DSHEA).8  Under DSHEA, a dietary supplement can 
generally be described as a product taken orally that contains a “dietary 
ingredient” intended to supplement the diet.  These dietary ingredients may 
include vitamins, minerals, herbs, and amino acids, among others.9 
Dietary supplement regulations in the United States are distinct from 
both food and pharmaceutical regulations.  Regulated primarily under 
DSHEA, the dietary supplement industry receives specific guidance for 
manufacturing and labeling of dietary supplements10  Importantly, in a stark 
departure from the regulation of pharmaceuticals, dietary supplement 
manufacturers do not have to prove the safety of their products before they 
enter the market; rather the burden of proof is on the U. S. Food and Drug 
Administration (FDA).11  Unfortunately, there is a subsequent history of 
unsafe dietary supplement products that have made their way into the 
market and have caused harm and even death to consumers.12  Public 
 
 6. See Peter Zambetti, Global Market Growth for Dietary Supplements (Apr. 17, 2008) 
(noting that Western and Eastern Europe’s global market shares for dietary supplements are 
14.4% and 2.7%, respectively), http://www.naturalproductsinsider.com/articles/2008/04/ 
global-market-growth-for-dietary-supplements.aspx. 
 7. For example, depending on the country and regulatory framework, dietary 
supplements may either be regulated with specific guidance (United States) or they may be 
regulated under general food or drug regulations (Australia).  See infra part III. 
 8. Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 
Stat. 4325 (codified as amended in scattered sections of 21 U.S.C.). 
 9. See 21 U.S.C. § 321(ff) (2006). 
 10. Id. §§ 342(g), 343(s). 
 11. Id. § 342(f). 
 12. See e.g., U.S. FOOD & DRUG ADMIN., INFORMATION PAPER ON L-TRYPTOPHAN AND 5-
HYDROXY-L-TRYPTOPHAN (2001) [hereinafter FDA INFORMATION PAPER] (noting that in 1989 an 
epidemic outbreak of eosinophilia-myalgia syndrome (EMS), which resulted in thirty-seven 
known deaths, occurred in the U.S. due to the use of dietary supplements containing L-
tryptophan), available at http://www.cfsan.fda.gov/~dms/ds-tryp1.html.  See also Editorial, 
The Ephedra Ban Is Not Enough, N.Y. TIMES, Jan. 5, 2004, at A16 (discussing the dangers of 
ephedra-containing weight loss products, “Ephedra has generated far more reports of adverse 
effects than any other supplement and has been linked to cases of heart attack, stroke and 
sudden death”). 
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outcry cast a shadow over the industry as a seeming lack of regulation was 
blamed for such adverse events.13 
U.S. lawmakers responded in the last few years to complaints 
concerning the need for more stringent dietary supplement rules with the 
adoption of two important regulatory changes.  In 2006, the Dietary 
Supplement and Non-prescription Drug Consumer Protection Act 
(DSNDCPA) was passed, requiring dietary supplement manufacturers to 
report to the FDA any serious adverse events potentially associated with their 
products.14  The DSNDCPA became effective on December 22, 2007.15  
Also, in June 2007, Congress adopted the FDA’s proposal for Current 
Good Manufacturing Practices for dietary supplements (CGMPs).16  The 
CGMPs create the minimum current good manufacturing practices for 
dietary supplement manufacturing, packaging, labeling, or holding of 
dietary supplements, in an effort to increase product quality17 and to help 
create a level playing field for supplement manufacturers.18 
With the passage of DSHEA, the DSNDCPA, and the CGMPs, it may 
appear that the government is strengthening its grip on the dietary 
supplement industry.  But in reality, the FDA’s power over dietary 
supplement manufacturers remains relatively weak.  The passage of DSHEA 
did not create a framework to restrict dietary supplements; it arguably 
created the opposite.  By placing the burden of proof on the government, 
DSHEA explicitly guarantees that dietary supplement manufacturers do not 
have to prove their products’ safety before marketing and sale of the 
products to consumers.  Even with the passage and implementation of the 
DSNDCPA and the CGMPs, dietary supplement regulation in the United 
States is widely open to criticism that the regulations do not ensure safety.19  
 
 13. See e.g., David Lazarus, Supplement Makers Need Stricter FDA Oversight, L.A. TIMES, 
Sept. 3, 2008, at C1 (arguing that dietary supplements should undergo pre-market testing in 
order to protect consumers). 
 14. Dietary Supplement and Non-prescription Drug Consumer Protection Act, Pub. L. No. 
109-462, 120 Stat. 3469, 3469 (2006) (codified at 21 U.S.C. § 379aa-1(b) (2006)). 
 15. Id. § 379aa-1(i). 
 16. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or 
Holding Operations for Dietary Supplements, 72 Fed. Reg. 34942, 34942 (June 25, 2007) 
(to be codified at 21 C.F.R. pt. 111). 
 17. Id. 
 18. Todd Zwillich, FDA OKs Dietary Supplement Regulations, WEBMD HEALTH NEWS, June 
22, 2007 (quoting Steve Mister, President and CEO of industry lobbying group, The Council 
for Responsible Nutrition, “I’m sure we won’t agree with everything in the rule, but we are 
pleased that the new GMPs are here as it’s a step forward for our industry.”), www.webmd. 
com/news/20070622/fda-oks-dietary-supplement-regulations. 
 19. See e.g., Katherine Wong, New Mandatory Reporting Requirements for Dietary 
Supplements and Nonprescription Drugs Solve Very Little, 35 J.L. MED. & ETHICS 336, 336 
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Further, when compared to dietary supplement regulations in jurisdictions 
that are also heavily influenced by dietary supplements—like the European 
Union, Japan, Canada, and Australia—current regulations in the United 
States are much less restrictive.  However, as this note argues, “less 
restrictive” does not necessarily mean that the regulations in the U.S. are 
inferior when compared to those abroad.  With the exponential growth in 
this newly regulated industry, it appears that most countries have yet to 
figure out how to adequately regulate dietary supplements.  Therefore, a 
critique of the recent dietary supplement regulations in the United States and 
a comparison to dietary supplement regulations abroad is necessary to 
provide guidance on how dietary supplement regulation in the United States 
should develop, and also to provide caution for potential problems. 
Part II of this article provides a historical background of dietary 
supplements’ turbulent past and their seemingly ever-increasing popularity.  
Next, as dietary supplement regulations around the world continue to 
change, Part III provides an overview of current dietary supplement 
regulations in the United States, European Union, Japan, Canada, and 
Australia, and addresses criticisms of DSHEA, the DSNDCPA, and the 
CGMPs.  Finally, Part IV analyzes the differences between the varying 
regulatory frameworks abroad with the dietary supplement regulations 
currently in place in the United States.  Based upon an international 
comparison of dietary supplement regulations, this note concludes that the 
United States is not alone in its struggle to properly address the regulatory 
needs of the expanding dietary supplement industry, and therefore, DSHEA, 
the DSNDCPA, and the CGMPs may be the targets of excessive criticism. 
II.  HISTORY OF DIETARY SUPPLEMENTS 
Although the term “dietary supplement” may be relatively new, the 
beneficial properties of certain vitamins and herbs have been appreciated 
for centuries.  Treatments using ancient Chinese herbs date back 2,500 
years to when healers employed herbal remedies to treat various 
afflictions.20  Such remedies are still used today around the world in what is 
now known as “traditional Chinese herbal medicine.”21  Likewise, Native 
Americans have used herbs such as echinacea for more than 400 years to 
 
(2007) (arguing that the DSNDCPA addresses some problems with DSHEA, but “it seems 
unlikely that it will substantially increase manufacturer or supplier accountability”). 
 20. See College of Traditional Chinese Medicine, University of Technology Sydney, 
History of Chinese Herbal Medicine, (noting that Chinese herbal medicine grew out of beliefs 
that herbs could protect individuals from evil forces), http://www.science.uts.edu.au/centres/ 
tcm/herbal.html (last visited Nov. 22, 2009). 
 21. See id. 
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treat wounds and injuries.22  In 2006 alone, American consumers spent an 
estimated $129 million on echinacea.23 
The understanding of vitamin properties was not developed until more 
recently, and scurvy played an important role.  Caused by a deficiency in 
vitamin C consumption, scurvy can manifest itself through skin bumps, leg 
hemorrhages, and swollen gums.24  “If we exclude straightforward famine, 
scurvy is probably the nutritional deficiency disease that has caused most 
suffering in recorded history.”25  In 1747, a British naval physician 
conducted an experiment where he provided lemons and limes to sailors 
who suffered from scurvy and quickly concluded that there were properties 
in the fruits that helped the sailors battle scurvy’s serious effects.26  
Consequently, British sailors carried limes onboard as part of their diets and 
earned the nickname “limeys.”27  Although the sailors did not know it at the 
time, the vitamin C that treated and protected them from scurvy would 
someday become one of the most popular dietary supplements in the world.  
Over time, the effects of vitamins, herbs, and amino acids continued to 
draw attention from scientists and ultimately progressed into the synthesis of 
thousands of specific dietary supplements that are available to consumers 
around the world. 
Today, dietary supplements maintain a high level of popularity because 
most consumers believe they are safe, effective, and good for health.28  
However, the dietary supplement industry is no stranger to controversy.  In 
1989, a dietary supplement containing the amino acid L-tryptophan was 
responsible for an outbreak of eosinophilia-myalgia syndrome (EMS) in the 
United States.29  EMS is a “painful blood disorder [that] can cause high 
fever, rash, weakness and shortness of breath, among other symptoms.”30  
The manufacturer of the dietary supplement, Showa Denko Inc., a Japanese 
company, cut corners in their purification procedures and experimented with 
 
 22. University of Maryland Medical Center, Medical Reference, Echinacea, (“Throughout 
history people have used echinacea to treat scarlet fever, syphilis, malaria, blood poisoning, 
and diphtheria.”) http://www.umm.edu/altmed/articles/echinacea-000239.htm (last visited 
Nov. 20, 2009). 
 23. Elizabeth Weise, Lancet: Echinacea Does Fight Colds, USA TODAY.COM, June 25, 
2007, http://www.usatoday.com/news/health/2007-06-25-echinacea-colds_N.htm. 
 24. Roger K. French, Scurvy, in THE CAMBRIDGE WORLD HISTORY OF HUMAN DISEASE 1000, 
1001 (Kenneth F. Kiple et al. eds., 1993). 
 25. KENNETH J. CARPENTER, THE HISTORY OF SCURVY & VITAMIN C vii (1988). 
 26. S.O. Waife, Lind, Lemons, and Limeys, 1 J. CLINICAL NUTRITION 471, 472 (1953). 
 27. Id. at 472-73. 
 28. MERCK RESEARCH LABORATORIES, THE MERCK MANUAL OF DIAGNOSIS AND THERAPY 2724 
(Mark H. Beers et al. eds., 18th ed., 2006) [hereinafter MERCK MANUAL]. 
 29. FDA INFORMATION PAPER, supra note 12. 
 30. Illness Is Tied to Way Diet Additive Was Made, N.Y. TIMES, Aug. 9, 1990, at D24. 
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bacteria to accelerate and increase the efficiency of production of their 
dietary supplement product that was used as a sleep aid.31  As a result, 
there were more than 1,500 reported cases of EMS associated with L-
tryptophan—of which there are at least thirty-seven known deaths.32  
Further, the actual number of people affected is estimated to be much 
higher.33  The FDA consequently took action to limit the availability of 
dietary supplements that contain L-tryptophan through advising consumers 
about the substance’s potential effects.34 
Similar to L-tryptophan, the dietary supplement ephedra has a deadly 
past.  Ephedra was marketed as a weight loss and bodybuilding supplement 
in the late 1990s and early 21st century.35  The supplement is an 
“amphetamine-like herb”36 that has been linked to seizure, heart attack, 
stroke, and death.37  By the end of 2001, ephedra was banned by the 
National Football League, National Collegiate Athletic Association, and the 
International Olympic Committee.38  Finally, at the beginning of 2004, 
ephedra became the first FDA-banned dietary supplement.39  Unfortunately, 
the ban was too late for many as it is believed that dietary supplements 
containing ephedra contributed to 155 deaths.40  The FDA ban stated that 
products containing ephedra “present an unreasonable risk of illness or 
injury,” and therefore are unsafe for consumers’ use.41 
The failure to resolve the ephedra issues until several years after the 
beginning of linked deaths is believed to be one of the biggest problems to 
face the dietary supplement industry in the first decade since the enactment 
 
 31. National Eosinophilia-Myalgia Syndrome Network, Eosinophilia-Myalgia Syndrome, 
http://www.nemsn.org (last visited Nov. 21, 2009). 
 32. FDA INFORMATION PAPER, supra note 12. 
 33. Id.  (“Some individuals suffering from L-tryptophan-related EMS have recovered, while 
other individuals’ illnesses have persisted or worsened over time.”). 
 34. See id. 
 35. See Nationwide Ban on Ephedra Goes into Effect: Judge Rejects Manufacturers’ 
Request to Halt Action, Apr. 13, 2004 [hereinafter Ephedra Ban], http://www.msnbc.msn. 
com/id/4721505/. 
 36. Id. 
 37. JENNA HOLLENSTEIN, UNDERSTANDING DIETARY SUPPLEMENTS 53 (2007). 
 38. Ephedra Ban, supra note 35. 
 39. Id. 
 40. Id. 
 41. News Release, U.S. Dep’t of Health & Human Services, FDA Announces Plans to 
Prohibit Sales of Dietary Supplements Containing Ephedra: Consumers Advised to Stop Using 
Ephedra Products Immediately (Dec. 30, 2003) (quoting FDA Commissioner Mark B. 
McClellan, “Consumers should stop buying and using ephedra products right away, and FDA 
will make sure consumers are protected by removing these products from the market as soon 
as the rule becomes effective.”), available at http://www.hhs.gov/news/press/2003pres/200 
31230.html. 
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of DSHEA.42  Annette Dickinson, the President of the Council for 
Responsible Nutrition, testified in front of the Subcommittee on Human 
Rights and Wellness that the delay in assessing the issues with ephedra was 
so monumental that it undermined consumer confidence in the entire dietary 
supplement industry.43 
However, for each L-tryptophan or ephedra controversy, there are 
thousands of dietary supplements that have not been linked to deaths or 
serious adverse events.  Millions of people safely take dietary supplements 
every day.44  But just because a dietary supplement is not dangerous does 
not mean that the dietary supplement has any actual value to maintaining 
health.  Some of the most popular vitamins and minerals used today have 
recently had their efficacy called into question. 
Initial tests and studies of vitamins suggested that they may help prevent 
cancer, stroke, and heart disease.45  In 2008, after the investment of 
hundreds of millions of dollars in clinical trials to further understand the 
capabilities of popular vitamins and minerals, two large trials failed to prove 
that vitamin C and vitamin E reduce the risk of certain cancers.46  However, 
the results of the clinical trials do not mean that vitamin C and vitamin E are 
worthless.  Vitamins may serve other important functions, as “[s]cientists 
remain convinced that vitamins are essential to health.”47  Further, the bad 
publicity surrounding the recent results of the clinical trials on vitamins may 
not be as significant for consumers as people may think.  Many American 
consumers believe that dietary supplements can lead to better health,48 
including data that suggests that fifty-seven percent of regular dietary 
supplement users in 1999 believed dietary supplement claims in 
advertisements generally were true.49  At the same time, only fifty-three 
percent of respondents to a different 1999 survey were aware that dietary 
supplements were not heavily regulated by the government.50 
 
 42. 10 Years After the Implementation of DSHEA: The Status of Dietary Supplements in 
the United States: Hearings Before the Subcomm. on Hum. Rights and Wellness, 108th Cong. 
8-9 (2004) [hereinafter Subcomm. on Human Rights] (testimony of Annette Dickinson, 
President of the Council for Responsible Nutrition). 
 43. Id. 
 44. See Council for Responsible Nutrition, supra note 3. 
 45. See Karen Kaplan, Vitamins Aren’t a Cure-All, L.A. TIMES, Dec. 21, 2008, at A1. 
 46. See id.  “This month, two long-term trials with more than 50,000 participants offered 
fresh evidence that vitamin C, vitamin E and selenium supplements don’t reduce the risk of 
prostate, colorectal, lung, bladder or pancreatic cancer.”  Id. 
 47. Id. 
 48. Robert J. Blendon et al., Americans’ Views on the Use and Regulation of Dietary 
Supplements, 161 ARCHIVES INTERNAL MED. 805, 806-07 (2001). 
 49. Id. at 808. 
 50. Id. 
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Consumers may also be unaware that certain popular dietary 
supplements may be dangerous when combined with prescription drugs or 
over-the-counter medications.  “Vitamins A, B6, B12, C, E and K; niacin; 
folic acid; calcium; magnesium; iron; and zinc can be hazardous when 
combined with various prescription drugs and over-the-counter remedies. 
Yet patients often fail to mention using such supplements to physicians.”51  
Even more worrisome, almost seventy percent of older adults who regularly 
take a prescription medication also take an over-the-counter medication, 
dietary supplement, or both.52  But data suggests that it may be difficult to 
discourage consumers from taking their favorite supplements.  Studies show 
that seventy-one percent of regular users of dietary supplements claimed 
that they would continue to take their most-used supplement even if a 
government agency told them the supplement was ineffective.53 
III.  DIETARY SUPPLEMENT REGULATIONS IN THE UNITED STATES AND ABROAD 
A. Regulations in the United States 
1. Dietary Supplement Health and Education Act 
Before DSHEA, the Food Drug & Cosmetic Act (FDCA) regulated dietary 
supplements as either foods or drugs because there still was no category for 
dietary supplements.54  The FDCA created food standards and mandated 
pre-market approval for all new drugs, but lumped vitamins, minerals, and 
herbs together as foods.55  Consequently, such substances received little 
regulation.56  Food and drug regulations developed over time, but it took 
until the 1990s for Congress to address the expanding market for dietary 
supplements by creating regulations specific to the dietary supplement 
industry. 
By the early 1990s, Congress focused its attention on legislation to 
address the questionable health claims made on nutritional product labels.57  
Two bills were considered: “One proposal would have strengthened the 
FDA’s enforcement powers and increased penalties for violating the [FDCA].  
 
 51. Jane E. Brody, Potential for Harm in Dietary Supplements, N.Y. TIMES, Apr. 8, 2008, 
at F7. 
 52. Roni Caryn Rabin, Seniors Mixing Prescription and O.T.C. Drugs, N.Y. TIMES, Jan. 8, 
2009, http://www.nytimes.com/2009/01/09/health/08seniors.html. 
 53. Blendon, supra note 48, at 807. 
 54. See Peter Barton Hutt, FDA Statutory Authority to Regulate the Safety of Dietary 
Supplements, 31 AM. J.L. & MED. 155, 155 (2005). 
 55. Id. at 156. 
 56. Id. 
 57. See Peter J. Cohen, Science, Politics, and the Regulation of Dietary Supplements: It’s 
Time to Repeal DSHEA, 31 AM. J.L. & MED. 175, 179 (2005). 
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The other would have imposed tight controls on the marketing of nutritional 
supplements by forbidding manufacturers to advertise therapeutic claims 
that, by law, could not be placed on the supplement’s label.”58  In response 
to potential regulations that would regulate vitamins and other supplements, 
the health-food industry mounted a massive lobbying campaign.59  “A 
coalition composed of health food stores, supplement users, the supplement 
industry, lobbyists, and sympathetic members of Congress created a new 
class of products and simultaneously declared that this new class would not 
be subject to the mission of the FDA.”60  Senator Orrin Hatch (R-UT) 
spearheaded the campaign and the Dietary Supplement Health and 
Education Act (DSHEA) of 1994 was signed into law by President Bill 
Clinton.61  “As a result, the necessary controls that the FDA was legally able 
to exert over prescription products were completely invalidated for dietary 
supplements . . . .”62 
DSHEA provides dietary supplements with their own specific regulatory 
framework, but the level of regulation DSHEA created over the dietary 
supplement industry is weak.63  Viewed optimistically, “[DSHEA] was passed 
in 1994 for two primary reasons: to ensure that consumers would continue 
to have access to a wide variety of safe dietary supplements and to provide 
consumers with more information about the dietary supplements they 
purchase.”64  However, such a statement is far too simplistic for the reach, 
or lack thereof, of the Act. 
Specifically, DSHEA classifies a dietary supplement as a product other 
than tobacco that is intended to supplement the diet; contains one or more 
dietary ingredients (including vitamins, minerals, herbs or other botanicals, 
amino acids, and other substances, concentrates, metabolites, constituents, 
extracts, or combinations of these ingredients); is intended for ingestion in 
powder, softgel, gelcap, capsule, tablet, or liquid form; is not represented 
for use as a conventional food or as the sole item of a meal or diet; and is 
 
 58. Id. 
 59. Id. 
 60. W. Steven Pray, Consult Your Pharmacist: The FDA, Vitamins, and the Dietary 
Supplement Industry, U.S. PHARMACIST, Oct. 2008, at 15. 
 61. Id. 
 62. Id. 
 63. See Michael H. Cohen, U.S. Dietary Supplement Regulation: Belief Systems and Legal 
Rules, 11 HASTINGS WOMEN’S L.J. 3, 4 (2000) (“DSHEA reaffirms that dietary supplements are 
‘foods’ and not ‘drugs,’ thus exempting dietary supplements from the requirement of new drug 
approval under the Federal Food, Drug & Cosmetic Act (FDCA).  A ‘drug’ includes, among 
other things, ‘articles intended for use in the diagnosis, cure, mitigation, treatment, or 
prevention of disease.’”). 
 64. Subcomm. on Human Rights, supra note 42, at 2. 
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labeled as a dietary supplement.65  These products can be purchased in a 
wide variety of stores throughout the country.  “Dietary supplements are the 
most commonly used of all complementary and alternative therapies, 
primarily because they are widely available and can be bought without 
consulting a professional health practitioner.”66 
Although the definition of a dietary supplement is liberal, there is an 
important distinction between traditional dietary supplements and new 
dietary supplements.  Dietary ingredients on the market prior to October 15, 
1994 were “grandfathered” into the regulations, allowing for their default 
marketing and sale.67  Therefore, dietary supplement manufacturers are 
allowed to continue to develop and market these “traditional” dietary 
supplements as they had before the passage of DSHEA.  New dietary 
ingredients, those not marketed in the United States before October 15, 
1994,68 face some specific hurdles.  New dietary ingredients may be 
allowed to be a part of a dietary supplement only if they 
have been present in the food supply as an article used for food in a form in 
which the food has not been chemically altered[or] [t]here is a history of use 
or other evidence of safety establishing that the dietary ingredient when used 
under the conditions recommended . . . will reasonably be expected to be 
safe . . . .69 
In order to bring new dietary ingredients to market, companies are required 
to notify the FDA about any new ingredient that the companies plan to 
market at least seventy-five days before actual marketing.70  Such 
notifications must provide a basis for the FDA to determine whether or not 
the new dietary ingredient is reasonably expected to be safe.71 
Another important regulatory element developed by DSHEA concerns 
the restrictions upon the types of claims dietary supplements can make.  
“Claims that can be used on food and dietary supplement labels fall into 
three categories: health claims, nutrient content claims, and 
structure/function claims.”72  Manufacturers and the FDA are responsible for 
ensuring the legitimacy of the claims made on dietary supplement labels, 
 
 65. 21 U.S.C. §§ 321(ff)(1)-(2) (2006); id. § 350(c)(1)(B)(ii). 
 66. MERCK MANUAL, supra note 28, at 2724. 
 67. 21 U.S.C. § 350b(c). 
 68. Id. 
 69. Id. § 350b(a)(1)-(2). 
 70. Id. § 350b(a)(2). 
 71. Id. 
 72. U.S. Food & Drug Admin., Claims That Can Be Made for Conventional Foods and 
Dietary Supplements (2003), http://www.fda.gov/Food/LabelingNutrition/Label Claims/ucm 
111447.htm [hereinafter Supplement Claims]. 
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while the Federal Trade Commission is responsible for the regulation of 
product advertising.73 
Health claims are considered claims that describe the relationship 
between the product and a reduction in the risk of a disease or health-
related condition.74  As opposed to claims that the dietary supplement may 
help prevent a condition, a dietary supplement “may not claim to diagnose, 
mitigate, treat, cure, or prevent a specific disease or class of diseases.”75  
An example of a permissible health claim for a dietary supplement could be: 
“Diets high in calcium may reduce the risk of osteoporosis.”76 
Nutrient content claims are different.  “Nutrient content claims describe 
the level of a nutrient or dietary substance in the product, using terms such 
as free, high, and low, or they compare the level of a nutrient in a food to 
that of another food, using terms such as more, reduced, and lite.”77  
Nutrient content claims typically only apply to dietary substances with 
recognized daily values recommendations.78  An example of a nutrient 
content claim could be: “Twice the omega-3 fatty acids per capsule (80 mg) 
as in 100 mg of menhaden oil (40 mg).”79 
Dietary supplement manufacturers may also describe the supplement’s 
effects on “structure or function” of the body or the “well-being” achieved 
through consumption of the supplement.80  Structure/function is understood 
“to refer to food label statements that describe the role of a nutrient or other 
dietary supplement ingredient in maintaining normal structure or function in 
humans (e.g. calcium builds strong bones) or to promote general well-
being.”81  As opposed to actual health claims, structure/function claims may 
not state or otherwise imply any relationship between the product and a 
disease or health condition.82  However, a structure/function claim may 
relate to a disease or health condition if the claim expresses how 
widespread the disease is in the United States.83 
 
 73. Id. 
 74. Id. (noting that the FDA regulates health claims through the 1990 Nutrition Labeling 
and Education Act (NLEA), the 1997 Food and Drug Administration Modernization Act 
(FDAMA), and the 2003 FDA Consumer Health Information for Better Nutrition Initiative). 
 75. 21 U.S.C. § 343(r)(6)(C). 
 76. Supplement Claims, supra note 72. 
 77. Id. 
 78. Id. 
 79. Id. 
 80. 21 U.S.C. § 343(r)(6)(A) (2006). 
 81. James E. Hoadley & J. Craig Rowlands, FDA Perspectives on Food Label Claims in 
the USA, in NUTRACEUTICAL AND FUNCTIONAL FOOD REGULATIONS IN THE UNITED STATES AND 
AROUND THE WORLD 115, 128 (Debasis Bagchi ed., 2008). 
 82. Id. at 128-29. 
 83. Id. at 129. 
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Regardless of the category the claim falls into, it is necessary for the 
manufacturer to have “substantiation that such statement is truthful and not 
misleading . . . .”84  Also, the product label must include: “This statement 
has not been evaluated by the Food and Drug Administration.  This product 
is not intended to diagnose, treat, cure, or prevent any disease.”85 
Finally, as previously noted the most controversial declaration DSHEA 
makes concerns the burden of proof for product safety.  Under DSHEA, 
dietary supplement manufacturers do not have to prove to the FDA that their 
product is either safe or effective before marketing or sale of that product.86  
The burden of proof in showing the safety of a dietary supplement was 
removed from the responsibilities of the manufacturer and shifted to the 
FDA.87 
In the last few years, dietary supplement regulation has consequently 
expanded to include new regulations that focus upon adverse event reports 
and good manufacturing practices. 
2. The Dietary Supplement and Non-prescription Drug Consumer 
Protection Act 
In order to monitor health problems associated with the use of 
pharmaceuticals and therapeutic biological products, the FDA relies on the 
compilation of adverse event reports.88  Adverse event reports are most well 
known for their application to pharmaceuticals.  “The Adverse Event 
Reporting System (AERS) is a computerized information database designed 
to support the FDA’s post-marketing safety surveillance program for all 
approved drug and therapeutic biologic products.”89 
When DSHEA was first passed, DSHEA notably did not contain a 
mandatory reporting requirement for adverse events related to dietary 
supplements.  However, apparently due to public outrage over the slow 
development of information and reaction related to the ephedra deaths, 
Senator Orrin Hatch (R-UT), along with Senators John Cornyn (R-TX), 
Richard Durbin (D-IL), Michael Enzi (R-WY), Thomas Harkin (D-IA), and 
Edward Kennedy (D-MA) introduced the Dietary Supplement and 
 
 84. 21 U.S.C. § 343(r)(6)(B) (2006). 
 85. Id. § 343(r)(6)(C). 
 86. Id. § 342(f). 
 87. Id. 
 88. FDA.gov, Adverse Event Reporting System (AERS), http://www.fda.gov/Drugs/ 
GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm (last 
visited Nov. 21, 2009). 
 89. Id. 
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Nonprescription Drug Consumer Protection Act (DSNDCPA).90  The 
DSNDCPA was signed into law by President Bush on December 22, 2006 
and came into effect on December 22, 2007.91 
The DSNDCPA attempts to improve consumer protection by requiring 
manufacturers to report adverse events.92 
The manufacturer, packer, or distributor of a dietary supplement whose 
name . . . appears on the label of a dietary supplement marketed in the 
United States . . . [is required to] submit to the Secretary any report received 
of a serious adverse event associated with such dietary supplement when 
used in the United States, accompanied by a copy of the label on or within 
the retail packaging of such dietary supplement.93 
The act classifies a “serious adverse event” as an “adverse event that 
results in death; a life-threatening experience; inpatient hospitalization; a 
persistent or significant disability or incapacity; or a congenital anomaly or 
birth defect; or requires, based on reasonable medical judgment, a medical 
or surgical intervention to prevent an outcome described [above].”94  The 
FDA evaluates the adverse event reports and determines whether or not 
regulatory action is necessary.95 
In September 2008, the FDA lowered its cumulative 2008 estimate for 
the total number of expected adverse event reports potentially related to 
dietary supplements from 960 to 856.96  For the first quarter of 2008, the 
FDA received a total of 214 mandatory reports of serious adverse events 
related to dietary supplements.97  However, it is estimated that the actual 
number of all adverse events relating to dietary supplements may be more 
than 50,000 per year.98 
 
 90. GovTrack.us, S. 3546: Dietary Supplement and Nonprescription Drug Consumer 
Protection Act, http://www.govtrack.us/congress/bill.xpd?bill=s109-3546 (last visited Nov. 
21, 2009). 
 91. 21 U.S.C. § 379aa-1(i). 
 92. Id. § 379aa-1(b)(1). 
 93. Id. § 379aa-1(b)(1). 
 94. Id. § 379aa-1(a)(2). 
 95. See FDA.gov, supra note 88 (stating in reference to the AERS system for drugs, 
“Based on an evaluation of the potential safety concern, FDA may take regulatory action(s) to 
improve product safety and protect the public health, such as updating a product’s labeling 
information, restricting the use of the drug, communicating new safety information to the 
public, or, in rare cases, removing a product from the market”). 
 96. Notice: Adverse Event Reporting and Recordkeeping for Dietary Supplements as 
Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act, 73 
Fed. Reg. 53253 (Sept. 15, 2008). 
 97. Id. 
 98. Id. at 53254. 
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Importantly, an adverse event does not necessarily signify the existence 
of a causal relationship.99  Some adverse events may be reported by people 
who already were ill and had been using either over-the-counter or 
prescription drugs at the time of the adverse event.100  Regardless, the FDA 
is required by law to investigate serious adverse events and subsequently 
determine whether or not the dietary supplement is the cause of the adverse 
event.101 
3. Dietary Supplement Good Manufacturing Practices Final Rule 
Another important rule recently developed for the dietary supplement 
industry concerns the creation and implementation of standards for the 
manufacturing of dietary supplements.  The pharmaceutical industry has 
required drug manufacturers to follow current good manufacturing practices 
(CGMPs) since they were adopted in 1963.102  In 2007, the FDA finalized 
CGMPs for the dietary supplement industry.103  As Janice Oliver, Deputy 
Director of the Center for Food Safety and Applied Nutrition explains, 
[t]he dietary supplement market has changed significantly since the passage 
of DSHEA.  The industry itself has grown exponentially and so has the 
number of Americans buying these products.  Access to dietary supplements 
has also changed.  Today a wide range of dietary supplements can be 
purchased in supermarkets or through the Internet.  The dynamic nature of 
this industry underscores the importance of and the necessity for Good 
Manufacturing Practice requirements for dietary supplements.104 
Given authority under DSHEA, the FDA published its proposed rule on 
CGMPs in 2003105 and the Final Rule was adopted June 25, 2007.106  The 
Final Rule creates the minimum CGMPs for dietary supplement 
 
 99. Natural Products Association, FDA Reports Lower Supplement AERs than Expected 
(Sept. 24, 2008), http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=222 
20&zoneid=2. 
 100. Id. 
 101. Id. 
 102. Current Good Manufacturing Practice in Manufacture, Processing, Packing, or 
Holding, 28 Fed. Reg. 6385, 6385 (June 20, 1963). 
 103. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or 
Holding Operations for Dietary Supplements, 21 C.F.R. § 111 (2007). 
 104. Janice Oliver, Deputy Director, Center for Food Safety and Applied Nutrition, 
Overview of the Implementation of the Current Good Manufacturing Practices for Dietary 
Supplements Guidance for Industry, FDA Satellite Broadcast (Oct. 24, 2007), http://www.fda. 
gov/Food/DietarySupplements/GuidanceComplianceRegulatoryInformation/RegulationsLaws/
ucm173996.htm. 
 105. Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary 
Ingredients and Dietary Supplements, 68 Fed. Reg. 12158, 12158 (proposed Mar. 13, 2003) 
(codified at 21 C.F.R. pt. 111). 
 106. 21 C.F.R. § 111 (2007). 
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manufacturing, packaging, labeling, or holding.107  Prior to the 
implementation of the recent Final Rule, dietary supplements were subject to 
the same manufacturing practice requirements as conventional foods.108 
The CGMPs provide requirements for the quality production of dietary 
supplements and ensures that the products are labeled properly and do not 
contain contaminants or impurities.109  The goal is to provide consumer 
confidence that the dietary supplements on the market have been 
manufactured to ensure their identity, purity, strength, and composition.110  
The FDA Commissioner Andrew Von Eschenbach remarked that “[t]his rule 
helps to ensure the quality of dietary supplements so that consumers can be 
confident that the products they purchase contain what is on the label.”111  If 
there is evidence of contaminants or the dietary supplements do not contain 
the dietary ingredients that they claim, then the FDA considers those 
supplements to be adulterated or misbranded and subject to regulatory 
action.112  However, it is important to note that the CGMPs do not require 
any proof of efficacy. 
The FDA estimates that there are 1,460 manufacturers, packers, and 
holders of dietary supplements.113  Depending on the size of the business, 
there is a specific date when the CGMPs take effect.114  For businesses with 
500 employees or more, the effective compliance date was June 25, 
2008.115  For businesses with 20–499 employees, the effective compliance 
date was June 25, 2009; and for businesses with fewer than twenty 
employees, the effective compliance date is June 25, 2010.116 
 
 107. 21 C.F.R. § 111 (2007); Current Good Manufacturing Practice in Manufacturing, 
Packaging, Labeling, or Holding Operations for Dietary Supplements, 72 Fed. Reg. 34752 
(June 25, 2007). 
 108. Subcomm. on Human Rights, supra note 42, at 5. 
 109. See 21 C.F.R. § 111 (2007); Press Release, FDA, FDA Issues Dietary Supplements 
Final Rule (June 22, 2007), http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce 
ments/2007/ucm108938.htm. 
 110. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or 
Holding Operations for Dietary Supplements, 72 Fed. Reg. at 34761. 
 111. Julia Sommerfeld, Dietary Supplements Face Stricter Regulations: For First Time, 
Companies Must Test Products for Contamination, FDA Says, MSNBC.COM, June 22, 2007, 
http://www.msnbc.msn.com/id/19370824/. 
 112. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or 
Holding Operations for Dietary Supplements, 72 Fed. Reg. at 34762-64; Press Release, supra 
note 109. 
 113. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or 
Holding Operations for Dietary Supplements, 72 Fed. Reg. 34752, 34920 (June 25, 2007). 
 114. Id. at 34752. 
 115. Id. 
 116. Id. 
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B. Regulations in other Countries 
Dietary supplements are not only popular in the U.S., but around the 
world consumers, manufacturers, and regulatory bodies have started to see 
the effects of an emerging and continually expanding market for dietary 
supplements.117  As one industry manager wrote in 2008, “[g]lobal demand 
for dietary and nutritional supplements continues to escalate—steadily in 
mature major markets and exponentially in smaller emerging markets.”118  
With demand for dietary supplements increasing, regulatory bodies have 
tried to keep pace in covering these products.  Some countries regulate 
dietary supplements with specific laws and regulations, while others regulate 
dietary supplements by categorizing them as either foods or drugs.  In order 
to analyze different regulatory approaches to dietary supplements, this 
section looks at dietary supplement regulations in large, developed dietary 
supplement markets outside of the U.S., with specific focus on regulations in 
the European Union, Japan, Canada, and Australia. 
1. Dietary Supplement Regulation in the European Union 
In 2007, Japan, the United States, and the EU represented roughly 
eighty-six percent of the global dietary supplement market.119  Dietary 
supplement regulation in the EU is grounded in Directive 2002/46/EC (the 
Food Supplements Directive), adopted June 10, 2002.120  The Food 
Supplements Directive was created as a comprehensive regulatory 
framework to resolve previous issues concerning the multiple regulatory 
bodies of the different member countries of the EU.121  Different national 
rules for dietary supplements “may impede their free movement, create 
unequal conditions of competition, and thus have a direct impact on the 
functioning of the internal market.”122  Therefore, regulation across the 
European Union is necessary.123 
The Food Supplements Directive specifies which food supplements may 
be sold in the European Union, using two different annexes—also known as 
the “positive list.”124  Since August 1, 2005, manufacturers, distributors, and 
 
 117. See Charles Thurston, Dietary Supplements: The Latest Trends & Issues, 
NUTRACEUTICALS WORLD, Apr. 2008, at 54. 
 118. Zambetti, supra note 6. 
 119. Thurston, supra note 117, at 54. 
 120. Council Directive 2002/46, On the Approximation of the Laws of the Member States 
Relating to Food Supplements, 2002 O.J. (L 183) 51, 51 (EC). 
 121. Id. 
 122. Id. 
 123. Id. 
 124. Id. at 51, 52. 
‘[F]ood supplements’ means foodstuffs the purpose of which is to supplement the 
normal diet and which are concentrated sources of nutrients or other substances with a 
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retailers of food supplements in Europe are prohibited from selling food 
supplements not listed on the positive list.125  As written, the positive list 
includes only thirteen vitamins in thirty-two possible forms, and fifteen 
minerals in eighty possible forms.126  If an EU member state wants to allow 
use of vitamins and minerals not included on the positive list, the state may 
do so until December 31, 2009 provided: 1) the substance was already in a 
supplement marketed in the state at the time of the adoption of the directive, 
and 2) the European Food Safety Authority has not given an unfavorable 
opinion of that substance based upon a dossier supporting the use of that 
substance.127 
For nutritional supplements on the market, the Food Supplements 
Directive contains requirements for the labeling of food supplements.  Labels 
of food supplements must contain: the term “food supplement”, the names 
of the categories of substances that characterize the product, the 
recommended daily portion of that supplement, a warning to not exceed the 
recommended daily portion, a statement that the supplement is not a 
substitute for a varied diet, and a warning that the product should be stored 
out of the reach of young children.128  Likewise, there are prohibited 
statements.  The food supplement label must not contain any statement that 
the product is capable of preventing, treating, or curing a human disease, 
or any statement or implication that a balanced diet cannot provide 
adequate amounts of the nutrients.129 
The Food Supplements Directive was met with massive opposition in 
Europe over the loss of consumer choice for certain products.  “The plans 
caused controversy from the start, prompting a petition of more than a 
million signatures, a letter of protest to Tony Blair from more than 300 
doctors and scientists, and motions opposing the law in both Houses of 
 
nutritional or physiological  effect, alone or in combination, marketed in dose form, 
namely forms such as capsules, pastilles, tablets, pills and other similar forms, sachets 
of powder, ampoules of liquids, drop dispensing bottles, and other similar forms of  
liquids and  powders designed to be taken in measured small unit quantities.   
Id. at art. 2.  Annex I provides the vitamins and minerals that are allowed, and Annex II 
provides the forms of those vitamins and minerals that may be used for the manufacture of 
food supplements.  Id. at art. 4. 
 125. See Council Directive 2002/46, art. 15, 2002 O.J. (L 183) 51, 55 (EC). 
 126. Id. at 55, 56. 
 127. Id. at art. 4 (noting that the deadline for submitting a dossier for consideration was 
July 12, 2005); Christine Eberhardie, Nutritional Supplements and the EU: Is Anyone Happy?, 
66 PROC. NUTRITION SOC’Y 508, 509 (2007) (noting that the application requirement had 
already resulted in applications for 421 substances). 
 128. See Council Directive 2002/46, art. 6, 2002 O.J. (L 183) 51, 55 (EC). 
 129. Id. at art. 6, 7. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
140 SAINT LOUIS UNIVERSITY JOURNAL OF HEALTH LAW & POLICY [Vol. 3:123 
Parliament.”130  In July, 2005, the European Court of Justice upheld the 
application of the Food Supplements Directive, effectively striking down an 
appeal from the health food industry challenging its legality.131  In the 
comparatively large supplement market of the UK, the Directive will ban 
roughly 300 forms of vitamins and minerals unless they are included on the 
positive list.132  Consumers consequently lost access to vitamins and 
minerals previously sold in the EU for many years.133 
2. Dietary Supplement Regulation in Japan 
Japan is another very important member of the dietary supplement 
industry.  As noted above, in 2007, Japan, the United States, and the EU 
represented roughly eighty-six percent of the global dietary supplement 
market.134  Dietary supplement regulation in Japan exists under a complex 
system of regulations that have developed and changed over time, but there 
still are no specific regulations or even a specific term for dietary 
supplements.135  Due to the complexity of the regulations that cover dietary 
supplements, it “may often make it difficult to comprehend the Japanese 
regulatory system of [health foods] for the food industry in foreign 
countries.”136 
In Japan, foods and drugs are regulated by the Japanese Ministry of 
Health, Labor and Welfare (MHLW).137  Since Japan does not specifically 
address dietary supplements in a statutory framework, dietary supplements 
instead fall under a network of food and drug regulations that have 
developed and changed multiple times within the last few years.138  In 1991, 
‘health foods’ (which are roughly analogous to dietary supplements in the 
 
 130. Sam Lister, Health Groups Lose Appeal on EU Food Supplement Ban, TIMES (London), 
July 13, 2005, at 14. 
 131. Id. 
 132. Id. 
 133. Id. (noting that the ‘positive list’ includes and allows the sale of vitamin C, calcium, 
and iron, but other “popular substances, such as selenium yeast, tin, manganese and vitamin 
K2, have been omitted and are subject to 505 separate appeals”). 
 134. Thurston, supra note 117, at 54; see Hirobumi Ohama et al., Health Foods and 
Foods with Health Claims in Japan, in NUTRACEUTICAL AND FUNCTIONAL FOOD REGULATIONS IN 
THE UNITED STATES AND AROUND THE WORLD 249, 275 (Debasis  Bagchi ed., 2008) (noting that 
Japan’s market for dietary supplements is “almost equivalent to the EU market” while 
accounting for $12.1 billion in 2006). 
 135. See Ohama et al., supra note 134, at 252. 
 136. Id. 
 137. See Paul Yamaguchi, Japan’s Nutraceuticals Today – A Big Disappointment in Food-
Drug Reclassification: Expectations Are Not Always Realized (Apr. 16, 2007), 
http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=18281&zoneid=45. 
 138. See id. (noting that food and drug reclassifications have been conducted “almost 
once a year, but over the last 3 years the agency still hasn’t completed one”). 
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U.S.) were integrated into the “Foods for Specified Health Uses” (FOSHU) 
system.139  “The Japanese government developed FOSHU to identify 
conventional foods that positively contribute to physiological systems in the 
human body from other foods by allowing these foods to have health claims 
and an approved logo printed on their package.”140  Substances that are 
considered dietary supplements in the U.S. would fall under either the drug 
regulations or the non-drug food regulations, depending on many different 
factors.141  “Many ingredients in the U.S. are still tightly guarded under 
Japan’s Pharmaceutical Affair Law.  They can’t be formulated into foods or 
supplements.”142 
Japanese food and drug regulations are strict and have prohibited open 
trade of dietary supplements between Japan and the U.S., resulting in 
requests to deregulate the ‘health food’ system and re-classify ingredients.143  
‘Reclassification’ can be understood as the process where the MHLW takes 
a product out from under drug regulations, and moves it under non-drug 
regulations.144  Once the MHLW allows an ingredient to move to a non-
drug status, the ingredient may be used as a supplement.145  Since 2001, 
the MHLW has reclassified a list of ingredients every few years.146  In 2007, 
MHLW released its fourth food-drug reclassification, which included fifty-five 
ingredients.147  Also of significant importance and seen as a sign of 
progress, in 2007 the MHLW for the first time announced that it intends to 
allow a public hearing concerning the products to be placed on the next 
reclassification list.148 
However, the nutritional industry in Japan still “needs a boost every few 
years in order to grow.”149  The downturn in the Japanese economy hit the 
 
 139. Paul Yamaguchi, Japan’s Nutraceuticals Today – FOSHU Ready to Change – Again 
(June 26, 2004), http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=104 
57&zoneid=45. 
 140. Id. 
 141. See Ohama et al., supra note 134, at 253, 257-58. 
 142. See Yamaguchi, supra note 137. 
 143. See Ohama et al., supra note 134, at 252 (noting that prior to 2001, “only the form 
of conventional foods was permitted while other forms such as tablets or capsules were not 
allowed”). 
 144. See Yamaguchi, supra note 137. 
 145. Id. (noting that in 2002, the supplement “CoQ 10 moved to non-drug status and the 
market grew from almost zero to $100 million in two short years”). 
 146. See id. 
 147. See id.  Categories include botanical, animal, and chemical ingredients.  Out of the 
55 ingredients reclassified, 33 were botanicals and only one was a chemical (L-citruline).  Id. 
 148. See id. 
 149. Paul Yamaguchi, Japan’s Nutraceuticals Today – Japan’s Economic Recovery Leaves 
Nutrition Industry Behind (Oct. 9, 2007), http://www.npicenter.com/anm/templates/news 
ATemp.aspx?articleid=19613&zoneid=45. 
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nutritional industry hard in 2006, and the nutrition market contracted for the 
first time in its history.150  But the economy is not the only factor to blame.  
“The Japanese nutrition industry, especially the nutritional supplement 
category, is still fragile and unsettled because of the lack of nutritional 
supplement laws.  Until the laws that recognize supplements are written, the 
Japanese nutritional supplement market will remain unsettled.”151 
3. Dietary Supplement Regulation in Canada 
In Canada, dietary supplements are known as natural health products 
(NHP), defined under the Natural Health Product Regulations.  Like 
Americans, Canadians have become heavy users of dietary supplements, as 
studies have shown that seventy percent of Canadians consume one or 
more natural health products.152  In 2006, it was estimated that the 
Canadian health products industry was worth $2.5 billion.153 
The Natural Health Products Directorate (NHPD), under the Health 
Products and Food Branch of Health Canada, acts as the regulatory 
authority for natural health products in Canada.154  Like the American 
system, dietary supplement products do not fit within the regulatory 
framework for pharmaceuticals, nor do they fit within the regulatory 
framework for foods.155  But in stark contrast to the American regulatory 
framework, the NHP Regulations require that NHPs obtain a product license 
through pre-market approval by the Minister of Health.156  The NHP 
Regulations place requirements upon manufacturers, distributors, importers, 
packagers, and labelers.157  As the Regulatory Impact Analysis Statement 
reports, “[t]hese Regulations are intended to provide Canadians with ready 
access to natural health products that are safe, effective, and of high quality, 
while respecting freedom of choice and philosophical and cultural 
diversity.”158 
 
 150. Id. (reporting that the Japanese nutrition market has averaged twelve percent annual 
growth over the last twenty years, but in 2006 the fell two percent). 
 151. Id. 
 152. CANADIAN HEALTH FOOD ASSOCIATION, supra note 5. 
 153. Id. 
 154. Regulatory Impact Analysis Statement of the Natural Health Products Regulations, 
137 C. GAZ. PART II, NO. 13 at 1571 (June 18, 2003) [hereinafter Regulatory Impact Analysis 
Statement] (the Regulatory Impact Analysis Statement is not part of the Natural Health 
Products Regulations). 
 155. Id. at 1592-93 (noting that “[i]t was decided the most effective regulatory mechanism 
was to create a new set of Regulations specific to NHPs . . .”). 
 156. Natural Health Products Regulations SOR/2003-196, s. 4(1) (Can).  An application 
for a product license requires specific information such as the recommended purpose of the 
NHP and supporting safety and efficacy data.  Id. at s. 5. 
 157. Id. at s. 2(1). 
 158. Regulatory Impact Analysis Statement, supra note 154, at 1571. 
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The NHP Regulations provide a regulatory structure for an estimated 
40,000 supplement products and traditional and alternative medicines.159  
NHPs include homeopathic and traditional medicines,160 as well as plants, 
fungi, vitamins, amino acids, essential fatty acids, minerals, and 
probiotics.161  NHPs must be safe enough to be considered for over-the-
counter use and must not require a prescription to be sold.162  Products that 
do require prescriptions are regulated under the Food and Drug 
Regulations.163  Once pre-market approval is given, NHPs can make “a full 
range of health claims, including structure-function, risk-reduction, and 
therapeutic or treatment claims.164 
To be considered an NHP, the product must have both a function 
component and a substance component.165  The function component covers 
substances which are 
manufactured, sold or represented for use in: the diagnosis, treatment, 
mitigation or prevention of a disease, disorder, or abnormal physical state 
or its symptoms in humans[;] restoring or correcting organic functions in 
humans; or modifying organic functions in humans, such as modifying those 
functions in a manner that maintains or promotes health.166 
The substance component is the medicinal ingredient of the product (which 
includes, among others, vitamins, minerals, and amino acids).167  NHP 
Regulations are mainly comprised of regulations pertaining to “definitions, 
product licensing, adverse reaction reporting, site licensing, good 
manufacturing practices, clinical trials involving human subjects, and 
labelling [sic] [and] packaging.”168 
Like American dietary supplement regulations, Canadians have adopted 
good manufacturing practices for NHPs.169  Canada also utilizes mandatory 
 
 159. Stephanie Martyres et al., Emerging Policies and Practices Under the Canadian 
Natural Health Product Regulations, in NUTRACEUTICAL AND FUNCTIONAL FOOD REGULATIONS IN 
THE UNITED STATES AND AROUND THE WORLD 159, 160 (Debasis Bagchi ed., 2008). 
 160. Regulatory Impact Analysis Statement, supra note 154, at 1574. 
 161. Natural Health Products Regulations SOR/2003-196, Schedule 1 (Can). 
 162. See id. at s. 2(2); see also Regulatory Impact Analysis Statement of the Natural Health 
Products Regulations, supra note 154, at 1572. 
 163. Natural Health Products Regulations SOR/2003-196, s. 2(2) (Can). 
 164. See Regulatory Impact Analysis Statement, supra note 154, at 1574. 
 165. Id. at 1573. 
 166. Id. 
 167. Id. at 1574-76. 
 168. Id. at 1578. 
 169. HEALTH CAN., NATURAL HEALTH PRODUCTS DIRECTORATE, GOOD MANUFACTURING 
PRACTICES GUIDANCE DOCUMENT i (2006), available at http://hc-sc.gc.ca/dhp-mps/alt_ 
formats/hpfb-dgpsa/pdf/prodnatur/gmp-bpf-eng.pdf. 
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adverse event reporting systems.170  The licensee or product license holder 
of a natural health product in Canada is required to report to Health 
Canada any adverse reactions that are associated with the use of its 
licensed natural health product.171  The licensee is required to develop and 
maintain procedures to properly collect information about adverse event 
reports, prepare and submit to Health Canada adverse reaction reports, 
and respond fully and promptly to Health Canada for additional safety 
information.172 
Critics of the NHP Regulations claim that the pre-market approval 
system is difficult on smaller companies due to the cost of compliance for 
product licensing.173  Critics also find that the costs of complying with the 
mandatory GMPs weaken incentives to create new products.174  Finally, 
industry members have been highly frustrated with the delay between 
applying for product approval and actual approval or denial.175  
Accordingly, “[t]he current regulatory environment has left everyone 
frustrated at the promise of the new regulations not being met.”176 
4. Dietary Supplement Regulation in Australia 
Australia does not contribute to a large portion of the global dietary 
supplement industry in terms of consumer sales, but it still provides an 
interesting regulatory framework for dietary supplements.  Australia and 
New Zealand share one framework for the regulation of foods, the Australia 
New Zealand Food Standards Code, but they do not agree on the 
regulation of dietary supplements or medicines.177  In Australia, the line is 
drawn between whether the ingested product is a food or a medicine—there 
is no classification for dietary supplements—while in New Zealand, dietary 
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supplements comprise their own specified category apart from food and 
medicine.178 
Without a specific category for dietary supplements, Australia employs a 
blanket approach to regulation.  Products such as vitamins, minerals, and 
nutritional supplements are regulated as complementary medicines under 
the Therapeutic Goods Act of 1989.179  Under the Act, dietary supplements 
are regulated equally with other ‘complementary’ medicines,180 allowing for 
a “substantially uniform national system of controls over therapeutic 
goods . . . .”181  The popularity of complementary medicines in Australia is 
signified by the fact that more than half of all Australians have used 
complementary medicines at least once, contributing to the estimated $2 
billion per year Australian complementary medicine market.182 
For all medicines, Australia separates them among different risk 
levels.183  “Most complementary medicines, including most vitamin and 
mineral supplements are considered to be low risk medicines, as they may 
only contain substances that have been approved by the TGA [Therapeutic 
Goods Administration] as being of low risk.”184  Through placement in this 
low-risk category, these products must be tested for both quality and safety, 
but are not required to be tested for effectiveness.185  Further, Australia 
requires that these complementary medicine products must conform to 
industry GMPs and that adverse event reports be submitted to the TGA.186 
However, even with the seemingly strict regulatory control, critics point 
out that by not requiring manufacturers to prove efficacy of low-risk 
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complementary medicines, consumers do not receive adequate information 
about the products and are therefore not protected through current law.187  
In response, Dr. Wendy Morrow, the Executive Director of the 
Complimentary Healthcare Council disagrees that Australian consumers 
need more product information.  Dr. Morrow states that the Australian 
complementary medicine regulations provide one of the “most scientifically 
rigorous regulatory frameworks for complimentary medicines 
internationally.”188  Dr. Morrow notes that two reviews of the complementary 
medicine framework have supported the risk-based regulatory system and 
proposed only minor modifications.189 
C. Back to the United States: Criticism of DSHEA, DSNDCPA, and CGMPs 
With a general understanding of U.S. dietary supplement regulations 
and other regulatory structures used around the world, there exists proper 
context to look at criticisms of the regulations in the U.S.  Like most 
controversial topics, criticisms concerning how the US handles dietary 
supplement regulations vary across a wide range of perspectives.  DSHEA 
itself has been targeted with the most disapproval as it is the backbone of 
dietary supplement regulation and it has been effective for much longer than 
more recent legislation. 
1. Criticism of DSHEA 
Critics of DSHEA have many different concerns, but only the most 
controversial will be discussed here.  First and most obvious, critics do not 
agree that the burden of proof for safety of dietary supplements should be 
the responsibility of the FDA.  “A major weakness in DSHEA is that it does 
not impose on all dietary supplements the burden and obligation to 
affirmatively substantiate their safety.”190  The FDA is a factor only after a 
product has already been on the market and it may only remove a dietary 
supplement from the market if it proves that the dietary supplement is 
adulterated.191  Therefore, the authority of the FDA largely appears to be 
reactionary as opposed to preventative, and consequently consumer safety 
is put at issue.  As L-tryptophan and ephedra have shown, a delay in 
assessing the dangers of a product can result in serious harm or even 
death.192  “DSHEA yielded significant latitude to dietary supplement 
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companies in manufacturing and promoting their products, arguably at the 
expense of consumer safety.”193 
As noted, the only substantiation claims that DSHEA requires are for 
dietary ingredients considered “new” after 1994.194  However, critics claim 
that “new” is classified in DSHEA in a narrow fashion that does not require 
substantiation for dietary supplements that were used before 1994 for a 
different purpose.195  They note that even though the dietary supplement 
may have been used prior to 1994, and therefore is “grandfathered” into 
protection, new uses of the supplement do not require safety 
substantiation.196  Consequently, new uses of the dietary supplement have 
no actual proof of consumer safety.  Therefore, some propose that if all 
dietary supplement manufacturers are required to substantiate the safety of 
their products, then the manufacturers would therefore use the necessary 
means to assure safety of the products and consumer safety would 
theoretically increase.197 
The criticisms of DSHEA hold the most weight when looking solely at 
DSHEA itself.  However, Congress attempted to appease critics with the 
passage of the DSNDCPA and the CGMPs. 
2. Criticism of the DSNDCPA 
While the DSNDCPA is an attempt to improve consumer safety by 
requiring dietary supplement manufacturers to report any serious adverse 
events to the FDA, it is likely too early to see realistic effects of the legislation 
because it only came into effect in December, 2007.  Critics, however, have 
found multiple areas of contention where the law may fail.  Critics argue 
that regardless of whether the reporting of adverse events is mandatory or 
not, the reporting inherently detects only a small proportion of the events 
that are actually due to the dietary supplement.198  This is because it 
requires the consumer or a medical professional to actually create the link 
between the event and the dietary supplement.199  This criticism may very 
well be accurate, but it is an inherent problem when dealing with adverse 
events.  An adverse event report intrinsically requires someone to make the 
determination that there is a link, or a possible link, between a substance or 
action and an outcome.  Therefore, some adverse events will surely never 
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be discovered.  The same issue necessarily exists for adverse event reporting 
in the pharmaceutical industry, or for that matter, any industry that follows 
adverse events. 
Critics also argue that some manufacturers may choose to risk 
investigation by the FDA rather than to turn over injurious adverse event 
reports because of worries about the effects the reports may have on 
business.200  However, the criticism that manufacturers will hide injurious 
information in order to protect profits is a criticism that can be made 
regardless of the law or particular level of regulation.  If a manufacturer is 
likely to hide injurious information under the rules established by the 
DSNDCPA, then there is no evidence whatsoever that those same 
manufacturers would not attempt to hide the injurious information if there 
were a different law in place. 
Finally, critics of the DSNDCPA argue that even if the FDA receives more 
adverse event reports, there are still both procedural and economic burdens 
that face the FDA.  Procedurally, the FDA still bears the burden of proof in 
order to show that a dietary supplement or nonprescription drug should be 
taken off of the market, and the DSNDCPA does not lighten the FDA’s 
burden.201  Economically, the DSNDCPA does nothing to heighten the 
priority of dietary supplement or nonprescription drug regulation by the FDA 
because doing so would mean more competition for the already strained 
resources of the FDA.202  Such criticisms seem valid at this point in time 
because the burden of proof that DSHEA created.  Until the FDA is allowed 
to shift the burden of proof for product safety back to the manufacturer, the 
FDA will have to continue to accurately budget expenditures. 
3. Criticism of the CGMPs 
Critics previously argued that DSHEA does not provide quality standards 
for strength and purity and there are no manufacturing standards mandated 
by the law.203  However, the CGMPs were created to specifically address this 
issue.204  The CGMPs provide specific guidelines for the manufacturing of 
dietary supplements.205 
Critics argue that the CGMPs do little for product safety.  Sidney Wolf, 
health director for FDA watchdog group Public Citizen remarked, “[e]ven 
with these new manufacturing practices, there will be no assurance that 
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dietary supplements work or are safe.”206  Similar to criticisms regarding the 
already-strained resources necessary to investigate adverse event reports, 
critics argue that there is a comparable strain on FDA resources for the 
enforcement of the CGMPs.207  If there are not enough resources to 
implement the law, then it is unlikely that consumers will receive the benefit 
of the law’s full potential.208  However, in the same manner, the argument 
that resources are too strained for the implementation of the CGMPs is 
arguably going to be applicable no matter what the law is because the FDA 
still must prioritize the use of resources. 
IV.  HOW A GLOBAL COMPARISON CAN HELP GUIDE THE UNITED STATES 
This note has demonstrated the level of controversy involved in dietary 
supplement regulation in the U.S., and how U.S. laws and regulations 
compare to those of other dietary supplement markets around the world.  
Surprisingly, the largest dietary supplement markets in the world have 
drastically different regulatory approaches to dietary supplement products.  
On one end of the spectrum, the U.S. supports the largest dietary 
supplement market in the world by providing the FDA with a relatively weak 
grasp on regulation.  However, the DSNDCPA and the CGMPs move 
regulation in the direction of a more restricted industry.  At the same time, 
Japan, Australia, Canada, and the EU are spread out along the continuum, 
but mostly remain at the opposite end of the spectrum where dietary 
supplements are much more strictly controlled.  Importantly, the strict 
regulatory control in Japan is moving away from the far end of the spectrum 
by allowing more products into the marketplace.  By no means are the 
regulations in the U.S. and Japan close to meeting in the middle, but they 
appear to be slowly heading in from the extremes. 
The EU made waves with the Food Supplements Directive by only 
allowing the sale of products on the positive list.  Consumers and industry 
members fought the Food Supplements Directive every step of the way.  It is 
safe to assume that if the same ‘positive list’ for dietary supplements in the 
EU were to be implemented in the U.S., the regulations would be met with 
equal, if not much more severe opposition.  For example, the health industry 
already used its clout to help promote DSHEA from the beginning.209  Surely 
a stronger and more politicized health food industry today would not cave 
easily into massively-restrictive regulations like the ones in the EU.  However, 
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as the EU updates substances for approval on the positive list, it also moves 
toward the middle of the regulatory spectrum. 
As regulations around the world change, it is important to remember 
that the regulation of dietary supplements is very new, and therefore may 
require multiple adjustments over time.  As one author commenting on a 
proposed Canadian natural health product bill said, “[the bill] is just the 
next step in this ongoing regulatory development process.”210  In this aspect, 
dietary supplement regulations around the world are developing a theme: 
regulation of dietary supplements is a process.  The U.S. adopted the 
DSNDCPA and the CGMPs in the last few years;211 Japan’s MHLW has 
changed and updated regulations multiple times since 2001;212 Canada 
continues to address new possible regulations as the market changes;213 
and the EU passed the Food Supplements Directive in 2002 and is working 
towards accepting more supplements onto its positive list.214  Australia, 
apparently content to regulate dietary supplements under the blanket 
framework for complementary medicines, is currently not considering 
amendments to its regulations.215 
Even if Congress gave the FDA the authority to control dietary 
supplements as strictly as other parts of the world, the FDA would not have 
enough funding to undertake the responsibility.  In 2007, a subcommittee 
looking at the state of the FDA published a report called “FDA Science and 
Mission at Risk.”216  The subcommittee found that the FDA is massively 
underfunded and understaffed for the responsibilities that it has governing 
foods, drugs, medical devices, cosmetics, and dietary supplements.217  
William Hubbard, a former FDA associate commissioner commented, 
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“[t]hese people were horrified by what they found,” and they determined that 
the FDA “cannot even do its job now.”218 
Support and criticism of DSHEA, the DSNDCPA, and the CGMPs show 
that the debate over the “correct” way to regulate dietary supplements in the 
U.S. will likely never cease, as money and lobbying have proved to be 
highly influential in the rulemaking process.219  Even though skeptics of the 
DSNDCPA and the CGMPs in the U.S. have criticized the rules by pointing 
out doomsday scenarios, the truth is that the actual effects on consumer 
choice and consumer safety have not yet been realized.  No other free-
market economy with a well-developed dietary supplement industry has yet 
found a regulatory framework that is either foolproof or free from 
controversy.  When one adds to the argument that dietary supplement 
regulation has only existed in the U.S. since 1994 and that the dietary 
supplement market continues to expand each year, it becomes evident that 
the proper direction for dietary supplement regulation must be heavily 
calculated. 
Finally, it does not appear that any of the regulatory frameworks in the 
world’s largest dietary supplement markets can be classified as model 
systems.  Each regulatory framework is both complex and unique to the 
market and culture that it serves, and each has its own advantages, 
disadvantages, criticisms, and praises. 
Commenting on the EU Food Supplements Directive, one author writes, 
“[i]t can be seen that the whole area of regulation for food supplements and 
traditional herbal remedies is complex and necessary but controversial.”220  
Controversy surely is one of the few things that all dietary supplement 
regulations have in common.  And if the past is any indication, controversy 
surrounding the regulation of dietary supplements is here to stay, regardless 
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